# Self-sampling for Non-attenders to Cervical Cancer Screening

> **NCT04226313** · NA · RECRUITING · sponsor: **The Institute of Molecular and Translational Medicine, Czech Republic** · enrollment: 15000 (estimated)

## Conditions studied

- Cervical Cancer
- Cervical Dysplasia
- Human Papillomavirus Infection

## Interventions

- **DIAGNOSTIC_TEST:** Self-sampling by Evalyn Brush
- **DIAGNOSTIC_TEST:** Self sampling by Evalyn Brush home or in GP´s clinic

## Key facts

- **NCT ID:** NCT04226313
- **Lead sponsor:** The Institute of Molecular and Translational Medicine, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-23
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 15000 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04226313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04226313, "Self-sampling for Non-attenders to Cervical Cancer Screening". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04226313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*